A detailed history of Black Rock Inc. transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Black Rock Inc. holds 5,664,419 shares of SRRK stock, worth $234 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,664,419
Previous 5,005,884 13.16%
Holding current value
$234 Million
Previous $88.9 Million 46.93%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.84 - $16.79 $5.16 Million - $11.1 Million
658,535 Added 13.16%
5,664,419 $47.2 Million
Q1 2024

May 10, 2024

BUY
$13.2 - $17.76 $571,388 - $768,777
43,287 Added 0.87%
5,005,884 $88.9 Million
Q4 2023

Feb 13, 2024

BUY
$6.52 - $20.32 $9.66 Million - $30.1 Million
1,481,952 Added 42.58%
4,962,597 $93.3 Million
Q3 2023

Nov 13, 2023

BUY
$6.02 - $7.76 $4.15 Million - $5.35 Million
689,674 Added 24.71%
3,480,645 $24.7 Million
Q2 2023

Aug 11, 2023

BUY
$5.79 - $9.11 $8.66 Million - $13.6 Million
1,495,618 Added 115.46%
2,790,971 $21 Million
Q1 2023

May 12, 2023

SELL
$7.36 - $12.72 $416,833 - $720,397
-56,635 Reduced 4.19%
1,295,353 $10.4 Million
Q4 2022

Feb 13, 2023

BUY
$7.02 - $9.76 $277,711 - $386,105
39,560 Added 3.01%
1,351,988 $12.2 Million
Q3 2022

Nov 14, 2022

BUY
$5.33 - $11.3 $1.19 Million - $2.52 Million
222,651 Added 20.43%
1,312,428 $9.1 Million
Q2 2022

Aug 12, 2022

SELL
$4.66 - $13.96 $5.52 Million - $16.5 Million
-1,184,751 Reduced 52.09%
1,089,777 $5.98 Million
Q1 2022

May 12, 2022

SELL
$11.89 - $24.68 $160,491 - $333,130
-13,498 Reduced 0.59%
2,274,528 $29.3 Million
Q4 2021

Feb 10, 2022

BUY
$24.14 - $35.18 $2.17 Million - $3.16 Million
89,921 Added 4.09%
2,288,026 $56.8 Million
Q3 2021

Nov 09, 2021

BUY
$27.38 - $42.21 $521,561 - $804,058
19,049 Added 0.87%
2,198,105 $72.6 Million
Q2 2021

Aug 11, 2021

BUY
$26.34 - $46.62 $57.4 Million - $102 Million
2,179,056 New
2,179,056 $63 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.13B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.